Working Paper Series

Pandemic Ethics

These Working Papers are part of a series of ethical commentaries written by the Centre for Biomedical Ethics(CBmE), Yong Loo Lin School of Medicine, National University of Singapore between February and June 2020 in the midst of an evolving pandemic. They were intended to provide information for healthcare professionals and decision-makers on ethical issues arising from the COVID-19  pandemic.

The  views  expressed  do  not,  in  themselves,  reflect  official  government policy on these matters. Contributors to the series are listed on the last page.

Pandemic Ethics 1
Care of Minors and Exposure of Uninfected Persons

Subsequent Publications
1) Voo, T. C., Lederman, Z., & Kaur, S. (2020). Patient Isolation during Infectious Disease Outbreaks: Arguments for Physical Family Presence. Public Health Ethics, 13  Issue 2, July 2020, Pages 133–142, doi: 10.1093/phe/phaa024

2) Voo, T. C., Senguttuvan, M., & Tam, C. C. (2020). Family presence for patients and separated relatives during COVID-19: physical, virtual, and surrogate. Journal of bioethical inquiry, 17(4), 767-772  doi: 10.1007/s11673-020-10009-8

Pandemic Ethics 2
Intensive Care Triage: Communication and Support for Patients and their Families, and Healthcare Workers
Pandemic Ethics 3
Allocation of Personal Protective Equipment (PPE) among Healthcare Staff
Pandemic Ethics 4
Allocation of Personal Protective Equipment (PPE) between Sectors or within Non-Healthcare Settings, and Issues Concerning Re-use
Pandemic Ethics 5
Ethical Considerations in the Event of a Critical Bed Shortage in Acute Hospitals
Pandemic Ethics 6
Experimental and Non-Standard Interventions for COVID-19

Subsequent Publications
1) Lysaght, T., Schaefer, G. O., Voo, T. C., Wee, H. L., & Joseph, R. (2022). Professional Oversight of Emergency-Use Interventions and Monitoring Systems: Ethical Guidance From the Singapore Experience of COVID-19. Journal of Bioethical Inquiry, 1-13. doi: 10.1007/2Fs11673-022-10171-1

AI Ethics

These Working Papers are part of a series written by the Centre for Biomedical Ethics(CBmE), Yong Loo Lin School of Medicine, National University of Singapore SHAPES programme in response to recent technological advancements in the world of AI and their impact on healthcare and biomedical research. They were intended to provide information for healthcare professionals, researchers, IRB members, academics, and decision-makers on ethical issues arising from these emerging technologies.

AI Ethics 1
Ethical Considerations for the Translational Application and Review of Biomedical Research Involving AI – A Briefing Document